Dr. Reddy's Laboratories Statistics
NYSE: RDYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.89+0.06 (+0.40%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Dr. Reddy's Laboratories by the numbers
Dr. Reddy's Laboratories has a market capitalization of $12.41 billion based on 833.66M shares outstanding. Its trailing P/E ratio is 41.4, and its forward P/E is 22.5. The stock trades 11.6% above its 50-day average and 11.9% above its 200-day average.
Average daily trading volume is 2.85M shares, or about $42.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RDY valuation vs. peer median
| Metric | RDY | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.41B | $10.64B | +17% |
| Forward P/E | 22.5 | 19.9 | +13% |
| Avg. volume | 2.85M | 1.56M | +83% |
Peer median across 8 companies: ELAN, BMRN, JAZZ, BBIO, TGTX, SYRE, MDGL, PRAX.
Valuation
- Market cap
- $12.41B
- P/E (TTM)
- 41.36
- Forward P/E
- 22.47
- Price / sales (latest FY)
- 3.26
- EPS (TTM)
- $0.36
- Shares outstanding
- 833.66M
Price and trading
- Previous close
- 14.83
- Open
- 14.88
- Day range
- 14.86 – 15.10
- 52-week range
- 11.36 – 15.67
- 52-week change
- +7.05%
- Beta
- —
- Volume
- 1.74M
- Average volume
- 2.85M
Dividends and events
- Annual dividend
- $8.00
- Dividend yield
- 53.73%
- Next earnings date
- Oct 23, 2026
Additional statistics
- Market Cap
- 12.41B
- Pe
- 41.36
- Forward Pe
- 22.47
- Eps
- 0.36
- Dividend Yield
- 56.00%
- Dividend Rate
- 8.00
- Week52 High
- 15.67
- Week52 Low
- 11.36
- Avg Volume
- 2.85M
- Shares Outstanding
- 833.66M
- Ma50
- 13.34
- Ma200
- 13.31
- Earnings Date
- Oct 23, 2026
- Pct From52w High
- -4.98%
- Pct From52w Low
- 31.07%